Xencor (XNCR) Free Cash Flow (2013 - 2026)
Xencor (XNCR) reported Free Cash Flow of -$68.2 million for Q1 2026, down 286.31% year-over-year from $36.6 million in Q1 2025, and down 29.11% quarter-over-quarter from -$52.9 million in Q4 2025.
Xencor (XNCR) Free Cash Flow (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Free Cash Flow data on file, last reported at -$68.2 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$68.2 million, down 286.31% year-over-year; the trailing twelve-month figure through Mar 2026 was -$188.8 million (down 11.77% YoY), and the FY2025 annual result was -$138.3 million, up 33.62% from the prior year.
- Free Cash Flow slipped to -$68.2 million in Q1 2026 per XNCR's latest filing, from -$52.9 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $31.9 million in Q2 2022 and troughed at -$70.4 million in Q2 2024.
- A 5-year average of -$30.9 million and a median of -$34.4 million in 2022 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2022 and 2023: Free Cash Flow jumped 367.36% in 2022, then tumbled 1211.03% in 2023.
- A 5-year view of Free Cash Flow shows it stood at -$34.4 million in 2022, then soared by 149.97% to $17.2 million in 2023, then plunged by 399.62% to -$51.5 million in 2024, then declined by 2.62% to -$52.9 million in 2025, then retreated by 29.11% to -$68.2 million in 2026.
- Business Quant data shows XNCR's Free Cash Flow at -$68.2 million in Q1 2026, -$52.9 million in Q4 2025, and -$31.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | -68.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68.24 Mn |
| Mar 31, 2026 | -68.24 Mn |
| Dec 31, 2025 | -52.85 Mn |
| Dec 31, 2025 | -52.85 Mn |
| Sep 30, 2025 | -31.00 Mn |
| Sep 30, 2025 | -31.00 Mn |
| Jun 30, 2025 | -36.75 Mn |
| Jun 30, 2025 | -36.75 Mn |
| Mar 31, 2025 | -17.66 Mn |
| Mar 31, 2025 | -17.66 Mn |
| Dec 31, 2024 | -51.50 Mn |
| Dec 31, 2024 | -51.50 Mn |
| Sep 30, 2024 | -29.42 Mn |
| Sep 30, 2024 | -29.42 Mn |
| Jun 30, 2024 | -70.38 Mn |
| Jun 30, 2024 | -70.38 Mn |
| Mar 31, 2024 | -56.99 Mn |
| Mar 31, 2024 | -56.99 Mn |
| Dec 31, 2023 | 17.19 Mn |
| Dec 31, 2023 | 17.19 Mn |